There are many different types of leukemia, and an accurate diagnosis is crucial for effective treatment. Leukemia is a cancer of bone marrow stem cells; the cells that develop into white blood ...

Further, compared to insulin use, GLP-1RA use was associated with a significantly reduced risk of lymphoid leukemia, myeloid leukemia, MPN, MDS, amyloidosis, non-Hodgkin lymphoma, monoclonal ...

The treatment you get for chronic lymphocytic leukemia (CLL) can slow your cancer, but it also might cause some physical and emotional side effects. Your doctor or mental health counselor can ...

Blood, The Journal of the American Society of Hematology, 2016, 127(20): 2375-2390. [2] Marks D I, Rowntree C. Management of adults with T-cell lymphoblastic leukemia[J]. Blood, The Journal of the ...

“For patients whose disease has progressed on EGFR TKIs and not treated with amivantamab and chemotherapy, chemotherapy alone ± anti–vascular endothelial growth factor (VEGF)-targeting ...

“It’s clearly what everybody’s been looking for.” In the wake of Summit’s results, drugs like ivonescimab, which block cell signaling via proteins called PD-1 and VEGF, have become the “new shiny ...

BCR-ABL1 is an abnormal gene present in certain types of leukemia. Genetic testing for BCR-ABL1 helps doctors diagnose these cancers and assess their response to treatment. If you or someone you ...

Acute myeloid leukemia (AML) is a type of blood and bone marrow cancer. AML can affect people of any age, but it is most common in adults. AML occurs when bone marrow produces abnormal blood cells ...

With over 300,000 new cases of ccRCC diagnosed globally each year and limited treatment options for patients who progress on VEGF-targeted therapies and immune checkpoint inhibitors, there remains a ...

For example, KOD’s Tarcocimab Tedromer is an anti-vascular endothelial growth factor [anti-VEGF] antibody biopolymer conjugate that’s currently in Phase 3. This candidate is being tested in ...